Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04278846 · ClinicalTrials.gov registry record · Phase 4
Efficacy of Liposomal Bupivacaine for Prolonged Postoperative Analgesia in Patient Undergoing Breast Reconstruction With Tissue Expander
A Phase 4 study, sponsored by The Cleveland Clinic.
- Completed
- Registry status
- Phase 4
- Development phase
- 50
- Enrollment target
NCT04278846 is a Phase 4 study that has completed, run by The Cleveland Clinic. The registered enrollment target is 50 participants.
The verdict
NCT04278846, a Phase 4 study, has completed, sponsored by The Cleveland Clinic.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 50 participants
- Enrollment target
Study Summary
Patients undergoing breast reconstruction with tissue expanders will be treated with a local anesthetic during their procedure and monitor their post-operative pain level and amount of oral pain medication taken. This information will be used to determine if liposomal bupivacaine provides better and longer pain control vs. bupivacaine HCl.
Interventions
- DRUG Depofoam bupivacaine
- DRUG Bupivacaine hydrochloride (HCl)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2014-08-22 |
| Est. Completion | 2019-05-15 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04278846
The ClinicalTrials.gov registry entry for NCT04278846 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Depofoam bupivacaine is the first listed.
NCT04278846 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04278846 about?
NCT04278846 is a clinical study titled "Efficacy of Liposomal Bupivacaine for Prolonged Postoperative Analgesia in Patient Undergoing Breast Reconstruction With Tissue Expander". Patients undergoing breast reconstruction with tissue expanders will be treated with a local anesthetic during their procedure and monitor their post-operative pain level and amount of oral pain medication taken. This information will be used to determine if liposomal bupivacaine provides better and...
What is the current status of trial NCT04278846?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2014-08-22. Estimated completion is 2019-05-15.
What interventions are being tested in trial NCT04278846?
The interventions under investigation include: Depofoam bupivacaine (DRUG), Bupivacaine hydrochloride (HCl) (DRUG).
Who is sponsoring clinical trial NCT04278846?
This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.